Does access to a colorectal cancer screening website and/or a nurse-managed telephone help line provided to patients by their family physician increase fecal occult blood test uptake?: Results from a pragmatic cluster randomized controlled trial

BMC Cancer

Volumn 14, Issue 1, 2014, Pages

  Clouston, Kathleen ^a   Katz, Alan ^a   Martens, Patricia J ^b   Sisler, Jeff ^c   Turner, Donna ^d   Lobchuk, Michelle ^a   McClement, Susan ^a   Crow, Gary ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b UNIVERSITY OF MANITOBA   (Canada)

^c Primary Care Oncology Program   (Canada)

^d CancerCare Manitoba   (Canada)

Author keywords

Cluster randomized controlled trial; Colorectal cancer screening; Community based family practice; Community based primary healthcare research; Fecal occult blood test; Integrated knowledge translation; Knowledge exchange; Patient decision aid; Pragmatic

Indexed keywords

ADULT; AGED; ARTICLE; CANADA; CANCER SCREENING; COLORECTAL CANCER; DECISION SUPPORT SYSTEM; FEMALE; GENERAL PRACTITIONER; HUMAN; INTERNET; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY (TOPIC); OCCULT BLOOD TEST; PATIENT DECISION MAKING; RANDOMIZED CONTROLLED TRIAL (TOPIC); TELECONSULTATION; COLORECTAL NEOPLASMS; CONTROLLED STUDY; MIDDLE AGED; OCCULT BLOOD; PATHOLOGY; PATIENT; PSYCHOLOGY; RANDOMIZED CONTROLLED TRIAL;

CANADA; COLORECTAL NEOPLASMS; FEMALE; HUMANS; INTERNET; MALE; MIDDLE AGED; OCCULT BLOOD; PATIENTS; PHYSICIANS, FAMILY;

EID: 84900841394     PISSN: None     EISSN: 14712407     Source Type: Journal    
DOI: 10.1186/1471-2407-14-263     Document Type: Article

References (28)

1. Canadian Cancer Society Canadian Cancer Statistics. 2012, http://www.cancer.ca/, Canadian Cancer Society.
2. Hewitson P, Glasziou P, Irwig L, Towler B, Watson E. Screening for colorectal cancer using the fecal occult blood test, Hemoccult. Cochrane Database Syst Rev 2007, 24(1):CD001216.
3. Flanagan WM, Le Petit C, Berthelot JM, White KJ, Coombs BA, Jones-McLean E. Potential impact of population-based colorectal cancer screening in Canada. Chronic Dis Can 2003, 24(4):81-88.
4. Hewitson P, Glasziou P, Watson E, Towler B, Irwig L. Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (Hemoccult): An update. Am J Gastroenterol 2008, 103(6):1541-1549. 10.1111/j.1572-0241.2008.01875.x, 18479499.
5. Statistics Canada Study: Mammography use and colorectal cancer testing. 2009, http://www.statcan.gc.ca/daily-quotidien/090630/dq090630c-eng.htm, Statistics Canada.
6. PRA Inc Colorectal cancer screening: Results of a survey of Manitobans 50-74 2008, Manitoba, http://www.cancercare.mb.ca/resource/File/CRC/Background_ColonCheck_Manitoba_Sept09.pdf, PRA Inc.
7. Canadian Cancer Society Canadian Cancer Society: Canadian Cancer Statistics, 2011 2011, Toronto, http://www.cancer.ca, Canadian Cancer Society.
8. Canadian Partnership Against Cancer The 2012 Cancer System Performance Report. 2012, http://www.partnershipagainstcancer.ca/wp-content/uploads/The-2012-Cancer-System-Performance-Report.pdf, Canadian Partnership Against Cancer.
9. Canadian Partnership Against Cancer Colorectal Cancer Screening in Canada: Current Facts and Resources 2010, http://www.cancerview.ca/idc/groups/public/documents/webcontent/rl_crc_snapshot_one_en.pdf, Canadian Partnership Against Cancer.
10. Stokamer CL, Tenner CT, Chaudhuri J, Vazquez E, Bini EJ. Randomized controlled trial of the impact of intensive patient education on compliance with fecal occult blood testing. J Gen Intern Med 2005, 20(3):278-282. 10.1111/j.1525-1497.2005.40023.x, 1490069, 15836533.
11. Fortin M, Lapointe L, Hudon C, Vanasse A. Multimorbidity is common to family practice: is it commonly researched?. Can Fam Physician 2005, 51:244-245. 1472978, 16926936.
12. Fortin M, Bravo G, Hudon C, Vanasse A, Lapointe L. Prevalence of multimorbidity among adults seen in family practice. Ann Fam Med 2005, 3:223-228. 10.1370/afm.272, 1466875, 15928225.
13. Yarnall KS, Pollak KI, Østbye T, Krause KM, Michener LJ. Priamry Care: Is there enough time for prevention?. Am J Public Health 2003, 93(4):635-641. 10.2105/AJPH.93.4.635, 1447803, 12660210.
14. Miller DP, Kimberly JR, Case LD, Wofford JL. Using a computer to teach patients about fecal occult blood screening. J Gen Intern Med 2005, 20(11):984-988. 10.1111/j.1525-1497.2005.0081.x, 1490260, 16307621.
15. Statistics Canada: CANSIM table 358-0130 http://www.statcan.gc.ca/.
16. Botting I, Katz A, . the Provincial health Contact Centre Congestive Heart Failure Committee Winnipeg Regional Health Authority, Research Evaluation Unit Research Evaluation Unit. Moving Forward In Integrating Chronic Disease Management With Primary Care: A Summary Of Qualitative Findings From The Chronic Disease Management Of Congestive Heart Failure Via Health Lines Demonstration Project. 2009, the Provincial health Contact Centre Congestive Heart Failure Committee Winnipeg Regional Health Authority, Research Evaluation Unit.
17. Crespi CM, Maxwell AE, Wu S. Cluster randomized trials of cancer screening interventions: are appropriate statistical methods being used?. Contempary Clin Trials 2011, 32(4):477-484.
18. Sisler J, McCormack-Speak P. Bridging the gap between primary care and the cancer system. Can Fam Physician 2009, 55(3):273-278. 2654827, 19282538.
19. Hintze J, . NCSS and PASS Number Cruncher Statistical Systems 2001, Kaysville, Utah, http://www.ncss.com, NCSS and PASS.
20. Campbell MK, Thomsom S, Ramsay CR, MacLennan GS, Grimshaw JM. Sample size calculator for cluster randomized trials. Comput Biol Med 2004, 34:113-125.
21. Clouston K, Katz A, Martens PJ, Sisler J, Turner D, Lobchuk M, McClement S, . the CIHR/CCMB Team in Primary Care Oncology (PCO-NET) Does a colorectal cancer screening patient aid provided by family physicians increase colorectal cancer screening rates?: a pragmatic cluster randomized controlled trial study protocol. BMC Cancer 2012, 12:182. http://www.ncbi.nlm.nih.gov/pubmed/22607726, 10.1186/1471-2407-12-182, 3495851, 22607726, the CIHR/CCMB Team in Primary Care Oncology (PCO-NET).
22. Christie J, O'Halloran P, Stevenson M. Planning a cluster randomized controlled trial: methodological issues. Nurs Res 2009, 58(2):128-134. 10.1097/NNR.0b013e3181900cb5, 19289934.
23. Schulz KF, Altman DG, Moher D, . for the CONSORT Group CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010, 340:c332. 10.1136/bmj.c332, 2844940, 20332509, for the CONSORT Group.
24. Adams AS, Soumerui SB, Lomas J, Ross-Degnan D. Evidence of self-report bias in assessing adherence to guidelines. Int J Qual Health Care 1999, 11(3):187-192. 10.1093/intqhc/11.3.187, 10435838.
25. Montaño DE, Phillips WR. Cancer screening by primary care physicians: a comparison of rates obtained from physician self-report, patient survey, and chart audit. Am J Public Health Nations Health June 1995, 85(6):795-800.
26. Holden DJ, Jonas DE, Porterfield DS, Reuland D, Harris R. Systematic Review: enhancing the use and quality of colorectal cancer screening. Ann Intern Med 2010, 152(10):668-676. 10.7326/0003-4819-152-10-201005180-00239, 20388703.
27. Steele RJC, Kostouru I, McClements P, Watling C, Libby G, Weller D, Brewster DH, Black R, Carey FA, Fraser C. Effects of age, gender and deprivation on key performance indicators in a FOBT based colorectal cancer screening programme. J Med Screen 2010, 17:68-74. 10.1258/jms.2010.009120, 20660434.
28. Physician Integrated Network. http://www.gov.mb.ca/health/phc/pin/index.html.